News
3h
MyChesCo on MSNCDC Panel Recommends GSK’s New PENMENVY Vaccine for AdolescentsThe U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...
8h
Healthcare Asia Magazine on MSNDoH, ADIO and GSK partner on Oncology Multi-Omics Institute in Abu DhabiThe institute will focus on oncology and aims to accelerate genomic science. The Department of Health – Abu Dhabi (DoH) and ...
In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...
GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.
Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Alector has completed subject enrolment in the 76-week, randomised, Phase II PROGRESS-AD trial, which is assessing the ...
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...
China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...
US Advisory Committee on Immunization Practices recommends approval of GSK’s RSV vaccines, Arexvy for adults aged 50-59: London, UK Saturday, April 19, 2025, 09:00 Hrs [IST] GSK ...
U.K. regulators cleared a multiple myeloma drug GSK withdrew from market three years ago. Elsewhere, an investment firm pressed Elevation Oncology to liquidate and the FDA relaxed risk monitoring ...
In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results